Anthropic unveils 'Claude Science' for scientific research

June 30, 2026 1:02 PM EDT

FILE PHOTO: Anthropic logo is seen in this illustration taken May 20, 2024. REUTERS/Dado Ruvic/Illustration/File Photo

June 30 (Reuters) - Anthropic ‌on Tuesday launched ​Claude ​Science, an AI research workbench, designed to help scientists streamline research, analyze data and manage ‌complex computing workflows.

The workbench offers scientists a user ⁠interface specifically designed for conducting research.

The launch is part of ‌Anthropic's life sciences and healthcare ‌initiative, which the IPO-bound company has been developing since October 2025.

Here are a few details on the ​launch:

• Claude Science combines databases, coding tools, compute and research workflows in one workspace, helping scientists analyze ⁠literature, run analyses, create figures and manuscripts, and trace results back to ​their source code and environment.

• The tool is pre-configured with more than 60 scientific databases ​and can render scientific artifacts such ‌as 3D protein structures, genome browser tracks and chemistry drawings, Anthropic said.

• Claude Science ⁠runs on Anthropic's existing Claude models, which have undergone the company's standard responsible scaling and biosecurity evaluations.

• Several research organizations ⁠and companies testing the platform in beta reported significant efficiency gains, ​Anthropic added.

• Anthropic is also launching its own pre-clinical drug programs, focused on neglected diseases, the AI startup's head of life ‌sciences Eric Kauderer-Abrams said during a press briefing.

• "These are areas that are outside the ‌scope of what the traditional pharma and biotech landscape ⁠might consider attractive targets, ‌but nonetheless have real ​burden associated with them," Kauderer-Abrams said.

(Reporting by Juby Babu in Mexico City; Editing by Vijay ‌Kishore)



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Reuters

Related Entities

IPO